Noile-Immune Biotech Inc.
4893.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥7,361 | ¥8,791 | ¥28,005 | ¥29,401 |
| - Cash | ¥4,670 | ¥5,556 | ¥4,521 | ¥4,141 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥2,691 | ¥3,236 | ¥23,484 | ¥25,260 |
| Revenue | ¥8 | ¥317 | ¥626 | ¥101 |
| % Growth | -97.6% | -49.4% | 521.2% | – |
| Gross Profit | ¥7 | ¥315 | ¥619 | ¥78 |
| % Margin | 97.4% | 99.3% | 98.9% | 77.3% |
| EBITDA | -¥1,069 | -¥775 | -¥106 | -¥768 |
| % Margin | -14,092.3% | -244.7% | -17% | -761.9% |
| Net Income | -¥964 | -¥1,130 | -¥387 | -¥795 |
| % Margin | -12,711.9% | -356.7% | -61.8% | -789.3% |
| EPS Diluted | -22.26 | -27.25 | -9.87 | -19.33 |
| % Growth | 18.3% | -176.1% | 48.9% | – |
| Operating Cash Flow | -¥888 | -¥873 | -¥107 | -¥777 |
| Capital Expenditures | ¥0 | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | -¥888 | -¥873 | -¥107 | -¥777 |